Neuropeptide Y and the Control of Catecholamine Secretion from the Adrenal Gland
Project Number7R01DK080441-02
Contact PI/Project LeaderWHIM, MATTHEW
Awardee OrganizationLSU HEALTH SCIENCES CENTER
Description
Abstract Text
DESCRIPTION (provided by applicant): The inner region of the mammalian adrenal gland is composed of sympathetic neurons that release the catecholamine hormones, epinephrine and norepinephrine, into the blood. During the fight-or-flight response, these hormones are released from the adrenal gland and prime the organism for the sudden demands that may be placed upon the circulatory, respiratory, musculoskeletal and metabolic control systems. Consistent with their wide-reaching actions, the inappropriate activity of the adrenal gland has been associated with a variety of diseases including hypertension. The long-term objective of the proposed study is to determine the mechanisms that normally control the release of these adrenal hormones. One control pathway is believed to involve the secretion of transmitters that are co-released with the catecholamines and that mediate "short feedback loops" within the gland itself. The identity of these co-transmitters and the condition(s) under which they released are not clear. However one strong candidate is neuropeptide Y, a polypeptide that is synthesized by chromaffin cells. Our hypothesis is that neuropeptide Y is an adrenal neurotransmitter whose release mediates short feedback loops that regulate catecholamine secretion. To test this hypothesis we have 3 specific aims that we will address using murine sympathetic neurons (chromaffin cells) and adrenal slices. In the first set of experiments we will test the hypothesis that the net effect of NPY is to increase the secretion of the catecholamines. Our second specific aim is to test the hypothesis that the release of NPY can regulate catecholamine secretion in an autocrine (cell-limited) manner. In the third set of experiments we will test the hypothesis that NPY can also regulate catecholamine secretion by altering the strength of the pre-synaptic input that normally limits catecholamine secretion. By using in vitro and in situ preparations and by employing electrophysiological and molecular techniques we will comprehensively determine whether local feedback pathways control catecholamine secretion. Although this work examines the regulation of the adrenal gland, similar mechanisms are likely to control the release of hormones from many different types of endocrine tissue. PUBLIC HEALTH RELEVANCE: The inner region of the adrenal gland secretes hormones that regulate blood pressure and the cardiovascular system. Understanding how the release of these molecules is controlled is needed for the development of treatments that could correct their inappropriate or excessive release.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdrenal GlandsAdrenal MedullaAdrenal hormone preparationAffectBloodBlood GlucoseBlood PressureCalciumCardiovascular systemCatecholaminesCellsChromaffin CellsCytoplasmic GranulesDiseaseDisputesEndocrineEpinephrineFeedbackGated Ion ChannelGlandHeart RateHormonesHypertensionImmune systemIn SituIn VitroKnock-outKnockout MiceMediatingMetabolic ControlMolecularMusMusculoskeletalNatureNeuronsNeurotransmittersNorepinephrineOrganOrganismPathway interactionsPatternPeptidesPhysiologicalPreparationProcessRNA InterferenceReceptor ActivationRegulationRoleSliceSpinalSpinal CordSurfaceSynapsesSynaptic ReceptorsSystemTechniquesTestingTissuesWorkautocrinecarbon fibercontrolled releaseexcitatory neuronfightinghormone control mechanismmeetingsneuropeptide Ypolypeptidepublic health relevancereceptorrelating to nervous systemresearch studyrespiratoryresponsetherapy developmentvoltagevoltage clamp
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
782627814
UEI
M7KCJ79FAVH5
Project Start Date
06-April-2009
Project End Date
31-March-2013
Budget Start Date
01-September-2009
Budget End Date
31-March-2010
Project Funding Information for 2009
Total Funding
$214,591
Direct Costs
$157,775
Indirect Costs
$56,816
Year
Funding IC
FY Total Cost by IC
2009
National Institute of Diabetes and Digestive and Kidney Diseases
$214,591
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R01DK080441-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01DK080441-02
Patents
No Patents information available for 7R01DK080441-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01DK080441-02
Clinical Studies
No Clinical Studies information available for 7R01DK080441-02
News and More
Related News Releases
No news release information available for 7R01DK080441-02
History
No Historical information available for 7R01DK080441-02
Similar Projects
No Similar Projects information available for 7R01DK080441-02